HE vs REGN · P/E 18, rev $799.2M vs P/E 14, rev $14.34B
Hawaiian Electric Industries Inc (HE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Hawaiian Electric Industries Inc (HE) is a utilities - regulated electric company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported HE revenue for 2024-12-31 was $799.2M. Net income was -$1.42B. Revenue was down 4.1% from 2024-09-30 to 2024-12-31. HE currently screens at market cap $2.26B and trailing P/E 17.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
HE currently screens at market cap $2.26B and trailing P/E 17.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the HE and REGN stock pages for the full models.
Not investment advice.